TD Cowen Maintains Buy on Boston Scientific, Raises Price Target to $86
Portfolio Pulse from Benzinga Newsdesk
TD Cowen analyst Joshua Jennings maintains a Buy rating on Boston Scientific (NYSE:BSX) and raises the price target from $77 to $86.
July 16, 2024 | 2:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TD Cowen analyst Joshua Jennings maintains a Buy rating on Boston Scientific and raises the price target from $77 to $86.
The raised price target and maintained Buy rating from a reputable analyst are positive signals for investors, likely leading to a short-term increase in BSX's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100